Notably, we found several significant (or close to significant) positive correlations between GFAP and insulin, as well as insulin resistance, after 3 months (r = 0.429, p = 0.018; r = 0.370, p = 0.044) and at the clinical follow-up (r = 0.408, p = 0.053; r = 0.525, p = 0.010) before age adjustments. The gene discussed is GFAP; the disease is Insulin resistance.